Cargando…
Corrigendum to “Inhibition of HIV-1 replication using the CRISPR/noNLS-Cas9 system as a prophylactic strategy” <[Heliyon 8 (9) (2022) e10483]>
Autores principales: | Salimi-Jeda, Ali, Esghaei, Maryam, keyvani, Hossein, Bokharaei-Salim, Farah, Teimoori, Ali, Abdoli, Asghar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014426/ https://www.ncbi.nlm.nih.gov/pubmed/36937033 http://dx.doi.org/10.1016/j.heliyon.2022.e12445 |
Ejemplares similares
-
Inhibition of HIV-1 replication using the CRISPR/cas9-no NLS system as a prophylactic strategy
por: Salimi-Jeda, Ali, et al.
Publicado: (2022) -
SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies
por: Salimi-Jeda, Ali, et al.
Publicado: (2021) -
Linear & Nonl. optics checks diring LHC injection tests
por: Fartoukh, S, et al.
Publicado: (2009) -
Molecular Epidemiology of Kaposi’s Sarcoma-Associated Herpes Virus, and Risk Factors in HIV-infected Patients in Tehran, 2014
por: Hesamizadeh, Khashayar, et al.
Publicado: (2016) -
HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals
por: Bokharaei-Salim, Farah, et al.
Publicado: (2020)